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Abstract
Background: In the Netherlands, suicide rates showed a sharp incline and this pertains particularly to the province
of Noord-Brabant, one of the southern provinces in the Netherlands. This calls for a regional suicide prevention
effort.
Methods/design: Study protocol. A regional suicide prevention systems intervention is implemented and
evaluated by a stepped wedge trial design in five specialist mental health institutions and their adherent chain
partners. Our system intervention is called SUPREMOCOL, which stands for Suicide Prevention by Monitoring and
Collaborative Care, and focuses on four pillars: 1) recognition of people at risk for suicide by the development and
implementation of a monitoring system with decision aid, 2) swift access to specialist care of people at risk, 3)
positioning nurse care managers for collaborative care case management, and 4) 12 months telephone follow up.
Eligible patients are persons attempting suicide or expressing suicidal ideation. Primary outcome is number of
completed suicides, as reported by Statistics Netherlands and regional Public Health Institutes. Secondary outcome
is number of attempted suicides, as reported by the regional ambulance transport and police. Suicidal ideation of
persons registered in the monitoring system will, be assessed by the PHQ-9 and SIDAS questionnaires at baseline
and 3, 6, 9 and 12 months after registration, and used as exploratory process measure. The impact of the
intervention will be evaluated by means of the RE-AIM dimensions reach, efficacy, adoption, implementation, and
maintenance. Intervention integrity will be assessed and taken into account in the analysis.
Discussion: The present manuscript presents the design and development of the SUPREMOCOL study. The
ultimate goal is to lower the completed suicides rate by 20%, compared to the control period and compared to
other provinces in the Netherlands. Moreover, our goal is to provide specialist mental health institutions and chain
partners with a sustainable and adoptable intervention for suicide prevention.
Trial registration: Netherlands Trial Register under registration number NL6935 (5 April 2018). This is the first
version of the study protocol (September 2019).
Keywords: SUPREMOCOL, Suicide prevention, Systems intervention, Stepped wedge trial design, Study protocol,
Collaborative care, Monitoring, Decision aid
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Background
Completed suicides and suicide attempts c physical
and emotional harm on the individual. Significant
others, the community, and even entire nations suffer
the consequences of such tragic events [1, 2]. Annu-
ally, more than 800,000 suicides occur worldwide, of
which over 56,000 were reported in the European
Union (EU), and almost 2000 in the Netherlands [1,
3, 4]. Although suicide rates in the Netherlands were
equal to the EU-average [3], they did show a sharp
incline of 37% between 2007 and 2013 [4]. This might
be related to the economic recession in 2008 and
rigorous budget cuts in the mental health sector [5,
6]. Since 2013, the relative suicide rate in the
Netherlands has been stable, without decreasing [4].
In Noord-Brabant, one of the twelve provinces of the
Netherlands, this stabilization in the suicide rates did
not take place, as the absolute number of suicide in
this province increased by 64%. Remarkably, 30% of
this 64% increase in completed suicides happened in
the years after 2013 [4]. At the start of the grant ap-
plication for this study in 2015, Noord-Brabant even
ranked second nationally over the five previous years
(2010–2014) and there were 293 suicides in 2014,
which is 11,5 suicides per 100,000 residents [4]. This
poses a problem in the Netherlands and more specif-
ically a regional problem in Noord-Brabant.
An important issue in effective suicide prevention is
that approximately two-thirds of suicide victims were
not receiving mental health care [7, 8], while they were
probably in need of it, as suicide occurs mostly in the
context of mental disorders [1, 2]. This might be due to
a lack of visibility of people at risk, as help-seeking be-
haviour for suicidality is low, possibly due to stigma and
poor suicide literacy [9]. Moreover, transitions of and
discharges from care are associated with an increased
risk of suicide attempt or death [10, 11]. An exploration
amongst stakeholders identified that a tentative explan-
ation might be a lack of communication between health
care providers of different institutions or lack of swift
entry into specialist care due to logistical barriers and
waiting lists.
Another problem concerns the identification of people
at risk for suicide since there are many risk factors
known that are also very common [2]. Suicide attempts
and suicidal ideation are among the strongest predictors
of completed suicide [1, 12]. Suicide risk is also elevated
in case of job and financial problems, unbearable mental
pain, lack of a support system, trauma, stigma, impulsive
aggression, hopelessness, living alone, and being faced
with loss [1, 2, 13]. In addition, suicide occurs more
often in males than in females [1]. The predictive power
of these individual risk factors is thus very low [2, 14].
There is yet no single tool, questionnaire or instrument
that can predict suicide [15]. Clinical assessment can
also be very hard, given the fact that about 45% of pa-
tients who died by suicide did meet with a primary care
provider in the preceding month [7]. A large (N = 4800)
longitudinal study found that prediction failed mostly, as
60% of patients that died by suicide had been catego-
rized before as low risk by mental health professionals
[16]. In the Netherlands, a Multidisciplinary Guideline
Diagnostics and Treatment of Suicidal Behaviour
(MGSB) was developed in 2012 [17]. A subsequent study
aimed at training professionals for the assessment and
treatment of suicidal behaviour -as recommended in this
MGSB- resulted in greater guideline adherence, but did
not result in lower suicide rates in the Netherlands so
far [18].
This urgently calls for a suicide prevention effort in
Noord-Brabant, aiming to reduce suicide by identifying
people at risk for suicide and by a collaborative effort to
improve the delivery of services by all relevant
stakeholders.
Rationale
This study considers completed suicides as mostly pre-
ventable deaths and in that vein will follow an example
of a regional systems intervention study of preventable
deaths in traffic trauma-related mortality in Orange
County, USA [19]. A regional network of Specialty Men-
tal Health Institutions, general hospitals, general prac-
tices, public health partners and community partners
(schools, railway services, municipalities, agricultural or-
ganizations) will be implemented with the aim to dimin-
ish preventable deaths by suicide in Noord-Brabant. Our
suicide prevention system is called SUPREMOCOL,
which stands for Suicide Prevention by Monitoring and
Collaborative Care, and is based on four pillars: [1] rec-
ognition of people at risk for suicide development and
implementation of a monitoring system with decision
aid, [2] swift access to specialist care of people at risk,
[3] positioning nurse care managers for collaborative
care case management, [4] and 12 months telephone fol-
low up.
Objectives
The aim of the present paper is to describe the content
of the SUPREMOCOL regional systems intervention and
the study design for the scientific evaluation. The four
pillars of the intervention are described in the paragraph
‘Intervention’ and the hypothesis for the scientific study
in the paragraph ‘Scientific evaluation’. The objective of
the SUPREMOCOL project is to lower suicide rates in
the province of Noord-Brabant, the Netherlands, by
20%. To this end, three sub-objectives are essential:
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1. Establishing the SUPREMOCOL systems
intervention, for persons at risk for suicide by
improving delivery of services by a well-functioning
chain of care on multiple levels, set up with the
purpose to remain available after ending of the
study.
2. Evaluate the effect of this multilevel suicide
prevention systems intervention in terms of
completed suicides and non-fatal suicide attempts
in an embedded evaluation.
3. Explore the public health impact of the suicide
prevention intervention by the RE-AIM framework,
including which factors (i.e. patient or transition
factors) are associated with early withdrawal of
treatment, taking the relevant stakeholders i.e. pro-
fessionals, patients and their significant others into
account.
Methods/design
Intervention
Framework
In the development of our suicide prevention interven-
tion we were inspired by a successful systems interven-
tion, that aimed to improve access to care by the
regionalization of trauma care for preventable traffic
trauma-related deaths in Orange County, California [20].
A combination of swift triage and entrance to designated
expert trauma care led to a decrease to one-eighth of the
previous rate of preventable deaths, i.e. deaths that could
have been prevented by better delivery of services [21].
Similar effects were found in several other regions
implementing the same systems intervention [22]. Sev-
eral key components of the intervention of West and
colleagues [23, 24], were translated to our specific target
group and context. One component is to work with the
concept of preventable death; as in the case of traffic
trauma, not all suicides may be preventable. This can,
for example, be the case in people experiencing unbear-
able suffering and suicidality due to severe mental disor-
ders combined with debilitating somatic illness. For our
systems intervention, we deemed suicides preventable if
they could be prevented by better delivery of services.
For example, if someone experiences suicidality due to a
psychiatric disorder which has been intensively -but yet
unsuccessfully- treated in primary care, a completed sui-
cide might be prevented by swiftly transferring the per-
son to specialist mental health care. This view has been
advocated by Wasserman et al. (2016), who coined a
completed suicide with the term unnecessary death [25].
Another component is to do first triage on the spot by
field professionals if indeed a preventable death is the
case. Moreover, providing trauma treatment, not at the
closest emergency room, but at the emergency room
where an experienced trauma team is available is also an
important component. This has been proven to be more
effective despite the initial time loss outside the hospital,
due to the high efficiency in the trauma specialist center,
once the patient arrives there [20]. Establishing swift ac-
cess to specialized trauma care in the institution itself in
a practical manner could also be translated into our ap-
proach. Our suicide prevention system is called SUPRE-
MOCOL, which stands for Suicide Prevention by
Monitoring and Collaborative Care, and focuses on four
pillars.
Pillar 1: development and implementation of a
monitoring system with decision aid
The first pillar concerns developing and implementing a
monitoring system with decision aid to support profes-
sionals in reporting, assessing and monitoring people at
risk for suicide. By using this system, we expect to iden-
tify more people at risk for suicide and to provide a tool
for suicide risk assessment. In the monitoring system,
both (mental) health care and non-(mental) health care
professionals are involved to signal people at risk and to
refer them to the closest specialist mental health care in-
stitution (SMHI). A decision aid is built-in to support
health care professionals in methodical/systematic,
evidence-based suicide risk assessment. The decision aid
for suicide risk assessment consists of two parts: the Pa-
tient Health Questionnaire-9 (PHQ-9) and an additional
risk assessment tool that is developed by the project
group. The PHQ-9 is a reliable and valid measure of de-
pression severity and has been proven useful in both
clinical and research practice [26]. In this study, the
Dutch translation is used. The scores comprise the time
period over the last 2 weeks and are 0 (not at all), 1 (sev-
eral days), 2 (more than half of the days), and 3 (nearly
every day) [26]. Item 9 of the PHQ-9 questionnaire had
been found to be a robust predictor of suicide attempts
and deaths, regardless of age [27], therefore, item 9 is
used in this study as a first screener for suicidality. In
this item, the person scores how often he/she is both-
ered by ‘Thoughts that you would be better off dead, or
thoughts of hurting yourself in some way’ [26]. Although
the whole PHQ-9 questionnaire will be filled out, suicide
risk will be only calculated based on the score on item 9.
If a person scores ‘0’ or ‘1’ on this item, suicide risk is
considered as low risk, while the suicide risk is consid-
ered as a medium to high if a person scores ‘2’ or ‘3’. If
the risk is medium or high, a second screener will follow
to further estimate the suicide risk, which is the decision
aid. This decision aid is developed by the project group
and is based on seven questions for suicide risk which
are answered with ‘yes’ or ‘no’ and is provided in
Table 1.
Based on the answers of the person, suicide risk is cal-
culated, which can be either high, moderate or low. The
Hofstra et al. BMC Psychiatry          (2019) 19:364 Page 3 of 17
suicide risk is estimated as high if the person answers
‘yes’ on question 4 or 5, or on both questions 3 and 6, or
if question 7 is answered by the clinician with ‘yes’. If
the person answers ‘yes’ only on question 3, or only on
questions 2 and 6, the estimated risk is moderate. The
suicide risk is otherwise estimated as low risk. This algo-
rithm is visually displayed in Fig. 1. In the monitoring
system, a cut-off is used, in which a moderate and high
estimated risk are both labelled as ‘increased risk’.
Non-health care professionals do not perform a suicide
risk assessment as they are not authorized to do so. When
they signal a person at risk for suicide, the risk assessment
will be performed in the SMHI, in the same manner. The
monitoring system also provides follow-up care from the
SMHI, which is described in pillar 2, 3 and 4.
Pillar 2: providing swift access
Providing swift access to people registered in the
monitoring system by specialist crisis teams of SMHIs
is the second pillar of our intervention. The first time
period after someone showed suicidal behavior re-
mains very vulnerable for relapse, as suicide occurs
mostly in people not receiving mental health care [7,
8] and in transitions of and discharges from care [10,
11]. But although suicide risk is thirty times higher in
people with a previous attempt [1], one attempt may
not necessarily be followed by another one, if proper
mental health care is provided after the attempt. Sui-
cide risk can also abate after a failed attempt. Out of
515 patients who attempted suicide at the Golden
Gate Bridge, 94% did not die from suicide, at a 26
years follow-up [28]. Moreover, it has been found that
appropriate pharmacological or psychotherapeutic
treatment may prevent suicide [15, 29]. A recent sys-
tematic review and meta-analysis indicated that sui-
cide prevention interventions were found to be
effective in preventing completed suicides [30]. Pro-
viding swift access to people identified with suicidal
behavior to specialist mental health care is thus
highly desirable. In this study, swift access will be fa-
cilitated by the monitoring system and will be pro-
vided by the SMHI. In case a persons’ suicidality is
not mainly caused by a psychiatric disorder, but for
example, due to financial or somatic problems, the
person might be referred to other (health) care set-
tings if that is more appropriate.
Table 1 Decision aid
Domain Question
In the past month 1. Did you have thoughts of being
better off when you were dead or did
you wish you were dead?
2. Did you want to hurt yourself?
3. Did you have thoughts about suicide?
4. Did you make suicide plans?
5. Did you attempt suicide?
In life 6. Did you have thoughts of being better
off when you were dead or did you wish
you were dead?
Clinical impression 7. Is there any acute danger in the behaviour
of the person?
Fig. 1 Algorithm of the decision aid
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Pillar 3: positioning nurse care managers according to
collaborative care
The third pillar of our intervention is the positioning of
nurse care managers to collaborate with psychiatrists in
assessment, case management, and guidance to treat-
ment according to the collaborative care model. Collab-
orative care is an intensive care model that involves a
number of health care professionals working together,
such as a medical doctor, a case manager, and a psych-
iatrist. The case manager has regular contact with the
person and organizes care, together with the medical
doctor and specialist, and may offer help. There is ample
evidence worldwide that collaborative care is successful
in the treatment of depression [31–35]. Collaborative
care has also been shown to be feasible, acceptable and
effective in the prevention and reducing suicidal ideation
[29]. A Cochrane review indicated that the implementa-
tion of treatment guidelines succeeds better if nurses are
trained with that purpose [36]. In this study, collabora-
tive care will be embedded in pillar two and four. Nurse
care managers will collaborate with the person and his/
her psychiatrist, clinical psychologist and general practi-
tioner in suicide risk assessment, providing swift access
to treatment, and monitoring. They will also signal po-
tential problems in the continuity of care and will com-
municate this with the involved professionals.
Pillar 4: providing one-year telephone monitoring
Providing telephone monitoring at five fixed times dur-
ing 1 year to people registered in the monitoring system
to enhance adherence to treatment is the fourth pillar of
our intervention. The first year after a person showed
suicidal behavior, usually many transitions within (men-
tal) health care settings occur. The risk of suicide is in-
creased during these transitions, as it has been found
that of those who have died by suicide and were previ-
ously receiving mental health care, 24% were discharged
in the previous 3 months. Most of these suicides already
occurred in the first week after discharge [37]. Often
there was non-compliance with treatment and loss of
contact with services prior to the suicide [37]. This
might be due to the lack of long-term monitoring follow
up of people at risk for suicide. Multiple reviews already
reported that structured follow-up contact with high-
risk individuals, such as people that attempted suicide,
decreased future suicidal behavior [11, 29]. Cebriá et al.
(2013) found in a randomized controlled trial that pro-
viding patients at a general hospital emergency room
that had attempted suicide with appropriate care and
telephone follow up reduced the rate of patients reat-
tempting suicide by 8%, compared to care as usual [38].
In our study, a one-year telephone follow-up care is pro-
vided to the people registered in the monitoring system.
This follow-up aims to monitor the suicide risk and the
continuation of care and is provided by the SMHI. The
SMHI professional will signal any problems in the moni-
toring contact, and will communicate this with the clin-
ician or general practitioner and will arrange new
appropriate care if needed.
Target population
The target population for the intervention are people
that present themselves to, or are identified by, a profes-
sional of one of the participating institutions by showing
signs of suicidal behavior. In this study, suicidal behavior
includes both suicidal ideations and actions -preparatory
and attempting- that are undertaken with the intention
to die [17]. Inclusion criteria for registration in the mon-
itoring system are 1) having a medium to high suicide
risk according to the decision aid (see paragraph ‘Frame-
work’ for the decision aid), 2) being a resident of the
province of Noord-Brabant, and 3) giving permission to
be registered in the monitoring system. People will be
excluded if 1) low suicide risk is assessed, 2) they are not
living in Noord-Brabant, and/or 3) they do not give con-
sent to be registered in the monitoring system.
Procedure of the intervention
The procedure of SUPREMOCOL is divided into three
steps. In the first step, a person with suicide risk is regis-
tered in the monitoring system. A first contact with the
crisis care manager is performed after registration, which
is the second step in the procedure. In the third step,
follow-up monitoring is provided to the people regis-
tered in the monitoring system. The four pillars of
SUPREMOCOL are embedded in all steps.
Step 1: registration in the monitoring system
In our systems intervention, both (mental) health care
professionals - such as emergency room physicians, gen-
eral practitioners or school psychologists - as well as
non-health care professionals - such as railway profes-
sionals - can signal people at risk and register them in
the monitoring system. When participating professionals
signal people at risk, they first ask them for permission
for registration in the monitoring system (according to
the European Union General Data Protection Regulation
[GDPR]). When permission for processing personal data
is given, professionals who work as a (mental) health
care professional perform a suicide risk assessment via
the decision aid, which is built-in the monitoring system.
The decision aid provides feedback based on the input
provided by the persons’ answers on a questionnaire and
observations made by the professional. If the suicide risk
is low according to the decision aid, the person will not
be registered and the professional is advised to refer the
person to his/her general practitioner. If the suicide risk
is medium or high, the person will be registered in the
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monitoring system, and their registration is automatic-
ally sent to the nearest SMHI, this is based on the postal
code of the person who will be registered. Professionals
that do not work in (mental) health care do not perform
a suicide risk assessment as they are not authorized and
trained to do so. They will register people in the moni-
toring system based on their own estimation. In these
cases, the risk assessment will be performed later on by
the SMHI crisis care professional who can use the deci-
sion aid to do so.
Step 2: first contact with the crisis care professional
The (daily) check for new enrolments in the monitoring
system is conducted by crisis care professionals from the
SMHI. This professional will actively seek contact on a
daily basis with the people registered. They will check if
a crisis assessment is necessary and they will ensure that
these people receive swift access to appropriate care,
most probably in the SMHI itself. SMHI professionals
will work according to the collaborative care model by
collaborating with the person and the involved profes-
sionals during 1 year. A flowchart of the first contact is
provided in Fig. 2 .
Step 3: follow-up monitoring
Telephone follow-up monitoring will be systematically
provided for one-year to monitor suicide risk and the
continuity of care by the SMHI professional in close col-
laboration with psychiatrists. The monitoring contacts
take place at five fixed times, i.e. 6 weeks after registra-
tion in the monitoring system, and after 3, 6, 9 and 12
months. In the monitoring contacts, the suicide risk will
be assessed and the person will be asked if he/she is re-
ceiving SMHI care. If the person is receiving SMHI care,
and the suicide risk is low, their clinician will be in-
formed by mail about the suicide risk assessment or the
person will be advised to inform their clinician him/her-
self. In case of a high suicide risk, the clinician will be
immediately informed by phone. If the person is not re-
ceiving SMHI care, and the suicide risk is low, their gen-
eral practitioner will be informed about the suicide risk
assessment. If the suicide risk is high, the crisis care
manager will again arrange swift access to appropriate
care. A flowchart of follow-up monitoring is provided in
Fig. 3.
Setting
The intervention will be implemented in Noord-Brabant,
one of the twelve provinces of the Netherlands. Noord-
Brabant comprises an area of over 5000 km2, about 2.5
million inhabitants and five specialist mental health in-
stitutions. Institutions can participate in the intervention
if they signal residents of Noord-Brabant at risk for sui-
cide. We will involve as many settings as possible that
can identify people at risk for suicide [39]. Therefore, we
do not only include mental health care institutions but
organizations in all other settings that might participate
by signaling people at risk for suicide. Examples are gen-
eral hospital emergency rooms and psychiatric depart-
ments, general practitioners, occupational physicians,
youth mental health care, schools, municipal services,
and railway services. All relevant institutions in Noord-
Fig. 2 Flowchart of the first contact
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Brabant will be approached for participation by the re-
searchers, but when interested, institutions can also con-
tact the researchers themselves. New chain partners may
be identified and included during the project. A list of
participating organizations can be obtained via the
authors.
Step-wise implementation
The intervention will be stepwise implemented in five
subsequent subregions of the province of Noord-Brabant
until eventually the system is implemented in the whole
province. In the time periods and subregions in which
the region is not allocated to the intervention conditions,
care as usual is provided. Further details about the step-
wise implementation are discussed in paragraph ‘Study
design’.
Scientific evaluation
Hypotheses
It is hypothesized that SUPREMOCOL will lead to a re-
duction of completed suicides of 20% in the province of
Noord-Brabant, both in time and compared to the other
provinces. Moreover, it is hypothesized that SUPREMO-
COL will lead to less completed suicides and suicide at-
tempts, both in association with the stepwise
implementation of the system intervention in the subre-
gions of the province, and will diminish suicidal ideation
in people registered in the monitoring system.
Study design
The design of the SUPREMOCOL study comprises three
elements: 1) a stepped wedge trial design, 2) a public
health impact evaluation by the RE-AIM framework and
3) an intervention integrity evaluation.
Stepped wedge trial design
The SUPREMOCOL intervention will be evaluated in a
stepped wedge trial design (SWTD). In a SWTD, an
intervention is sequentially rolled-out to a group of clus-
ters. A cluster is a group of participants that operate in
the same geographical area. In our study, a cluster is a
specialist mental health care institution together with a
group of participating general practitioners, hospitals,
and other organisations that operate in that particular
SMHI area. We chose a SWTD for ethical, scientific and
practical reasons, as further discussed in the ‘Discussion’
of this paper. Stepped wedge trials comprise three main
phases: the pre-rollout period, the rollout period and the
post-rollout period [40, 41]. In period 0, the so-called
pre-rollout period, the intervention has not been
Fig. 3 Flowchart of the follow-up monitoring
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implemented in any of the clusters. Next, there will be a
rollout period during which clusters are crossing over
from the control condition (in this study care as usual)
to the intervention (SUPREMOCOL). In period 1, the
intervention will be implemented in cluster 1, while the
other clusters will keep providing care as usual. In
period 2, the intervention will also be implemented in
cluster 2 (cluster 1 will still be included), while the other
clusters will keep providing care as usual, and so on. In
the post-rollout period, the intervention will be imple-
mented in all clusters. A schematic representation of the
present SUPREMOCOL trial is given in Fig. 4. Each cell
represents a time period and a certain cluster and in-
cludes a data collection point. Blank cells represent con-
trol periods and shaded cells represent intervention
periods [41, 42].
In our SWTD, the implementation of SUPREMOCOL
is sequentially rolled-out to five clusters, until eventually
the system is implemented in the whole province. For
this purpose, the province is divided into five sub-areas
that are based on the service areas of the five participat-
ing SMHI’s. The SMHI and a few participating organiza-
tions are exposed to the experimental condition from
the start of their cluster, but at various time points, more
organizations in that cluster may participate if they sign
up for participation [40].
Public health impact evaluation
The public health impact of the SUPREMOCOL inter-
vention will be evaluated, as previous studies found that
it is important to not only assess the efficacy of an inter-
vention but to also evaluate its impact [43]. For example,
an intervention might be very successful in an optimal
and controlled experimental condition but might have
poor implementation outcomes in complex real-world
settings [43]. As a result, many interventions that were
found to be effective were never widely adopted in prac-
tice [44]. The evaluation to the public health impact of
SUPREMOCOL will be done in terms of the five dimen-
sions - Reach, Efficacy, Adoption, Implementation, and
Maintenance - of the RE-AIM framework [43]. Reach re-
fers to the extent of participation, on an individual level.
It can be measured by calculating the rate of the numer-
ator (participants) versus the denominator (population).
Additionally, the representativeness of the participants
can be assessed by evaluating their characteristics [43].
In this study, reach is the level in which SUPREMOCOL
is used by the target population (both patients and pro-
fessionals) and to their characteristics. Efficacy refers to
the positive and negative consequences of the interven-
tion and to behavioural and participant satisfaction out-
comes [43]. In this study, changes in the outcome
measures (suicidal behaviour), compliance with interven-
tion procedures and experiences of patients and profes-
sionals with the system were measured to evaluate the
efficacy of SUPREMOCOL. The proportion and repre-
sentativeness of the settings that participate refer to the
dimension adoption [43]. The level in which settings and
professionals are willing to initiate the system, including
their characteristics, are examined to measure this di-
mension in this study. Implementation is an individual-
and intervention-level dimension and refers to the extent
to which an intervention is delivered as intended [43]. In
this study, implementation is defined as the level in
which the system is implemented according to the
protocol. The last dimension is Maintenance, which
Fig. 4 Sequential rollout of the suicide prevention system (shaded cells) to the clusters
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refers to the extent to which the intervention is part of a
long-term behavioural change in individuals and organi-
sations and has reached a stable and enduring phase
[43]. Maintenance is in this study examined by an evalu-
ation of the long-term compliance with intervention
procedures and by attrition analyses.
Intervention integrity evaluation
Intervention integrity will be measured during imple-
mentation. This will be done to gain insight into 1) the
extent to which the four pillars of the SUPREMOCOL
protocol are implemented in clinical practice as
intended, 2) the proportion of settings and practices that
adopted the SUPREMOCOL study into their clinical
practice, and 3) the proportion of the target population
that participated in the SUPREMOCOL study.
Allocation
If possible, block-wise randomisation will be performed
to determine the starting order of the SMHI areas. The
‘blocks’ of areas will be based on the SMHI’s level of im-
plementation and organization, as the implementation of
the intervention requires a lot of preparation from the
SMHI’s. The block-wise randomization will take place in
three steps. First, the SMHI will receive a proposal re-
garding the implementation of the intervention. Six cri-
teria indicate the extent to which the SMHI is ready for
the implementation of SUPREMOCOL. The six criteria
are that the SMHI: 1) has a contact person that will be
involved in preparing the SMHI for implementing the
intervention, 2) provides permission from the board to
start the implementation, 3) has set up a team that will
provide the daily check for new enrolments in the moni-
toring system, including providing a first contact with
the person, 4) has set up a team that will provide moni-
toring contacts to the people registered, 5) has received
the instructions for working with the monitoring system,
and 6) has tested the monitoring system. Second, three
blocks will be created, based on the organizations’ level
of implementation and organization. Therefore, the
three blocks will be: ‘replies to the proposal and is
ready to start with the implementation’ (group a), ‘re-
plies to the proposal and is not yet ready to start
with the implementation’ (group b) and ‘does not
reply to the proposal’ (group c). Third, randomization
will take place within the SMHI’s which belong to
block a. In this manner, the remaining organizations
have extra time to prepare for implementation. If
there is only one SMHI in a group, the SMHI will be
randomized with a dummy. The districts will be ran-
domized by an independent statistician using a com-
puter algorithm for randomization.
Outcomes
The primary outcome of this study is completed suicides
and the secondary outcome is suicide attempts. Suicidal
ideation will, if possible, be an exploratory process meas-
ure. Moreover, the impact of the intervention and inter-
vention integrity will be measured. The outcomes and
their data collection methods are discussed below.
Primary outcome: completed suicides
The primary outcome of this study is completed sui-
cides. In the Netherlands, the occurrence of completed
suicide is registered by coroners in the ORION system.
The records from the ORION system regarding Noord-
Brabant will be obtained from the Regional Public
Health Institutes (PHI [in Dutch: Gemeentelijke
Gezondheidsdienst; GGD]): GGD Brabant-Zuidoost,
GGD West-Brabant, and GGD Hart voor Brabant. The
PHI’s report their records to Statistics Netherlands, who
collect the records for the whole country and make cor-
rections if needed. To evaluate whether SUPREMOCOL
leads to a reduction of completed suicides of 20% in the
province of Noord-Brabant (hypothesis 1), completed
suicides will be assessed during a one-year pre-post
measurement for the total population of the province of
Noord-Brabant. The pre-measurement will take place in
the year before any of the areas in Noord-Brabant have
entered the roll-out period (thus: 1 year before the start
of period 1 of the SWT; therefore including period 0 of
the SWT), and the post-measurement will take place in
the year after implementation in all areas (thus: after
period 5 of the SWT). National records from Statistics
Netherlands will also be used for the pre-post evaluation,
as completed suicide rates will be compared in time
(pre-post) and per region (Noord-Brabant versus other
provinces in the Netherlands). As it is also hypothesized
that SUPREMOCOL leads to a reduction of completed
suicides and suicide attempts in association with the
stepwise implementation of the system intervention in
the subregions of the province (hypothesis 2), completed
suicides will also be assessed during the stepped wedge
trial in the subregions of Noord-Brabant. Regional PHI
records will be used for the SWT evaluation. For this,
the total number of completed suicides per month will
be examined.
Secondary outcome: Suicide attempts
As suicide attempts and suicidal ideation are among the
strongest predictors of completed suicide [1, 12], these
two measurements are taken into account in the analysis
as well. To evaluate whether SUPREMOCOL leads to a
reduction in suicide attempts in association with the
stepwise implementation of the system intervention in
the subregions of the province (hypothesis 2), the sec-
ondary outcome is the rate of attempted suicides in the
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subregions of Noord-Brabant. This will be evaluated
during the stepped wedge trial. The number of suicide
attempts will be estimated based on two measurements:
1) the number of ambulance rides that took place after a
suicide attempt, which will be provided by the PHI
(GGD Brabant-Zuidoost; Ambulancezorg Zuidoost-
Brabant) and the regional ambulance transport (Regio-
naal Ambulancevervoer Brabant Midden-West-Noord),
and 2) on the basis of police registrations as provided by
the police. The police registrations comprise E14 re-
ports, which are records of incidents for which the po-
lice arrived due to an “attempted suicide”.
Exploratory process measure: suicidal ideation
To evaluate whether SUPREMOCOL leads to a reduc-
tion in suicidal ideation in people registered in the mon-
itoring system, if possible, suicidal ideation will be
measured by PHQ-9 and SIDAS questionnaires via an
online survey. This will be measured at baseline and
after 3, 6, 9 and 12 months. Suicidal ideation will also be
measured by the PHQ-9 and decision aid outcomes as
filled out in the monitoring system at registration, and
during the monitoring contacts at 6 weeks, and 3, 6, 9
and 12months after registration. For the latter, no extra
actions from the person are requested as these question-
naires are already filled out for regular care. The Patient
Health Questionnaire-9 (PHQ-9) is a reliable and valid
clinical and research tool for the measurement of de-
pression severity [26]. The Suicidal Ideation Attributes
Scale (SIDAS) is a valid measure for severity of suicidal
ideation [45]. Questionnaires will be as short as possible
to promote participant retention and complete follow-
up; the PHQ-9 questionnaire consists of nine questions
and the SIDAS of five questions.
Exploratory process measure: suicidal behaviour in SMHI
patients
Suicidal behaviour in SMHI patients will be measured
and taken into account in the analysis of the stepped
wegde trial. It will be measured by SMHI records about
the number of completed suicides among their patients
and admissions into their institution due to suicide risk.
The measurement period will take place during the
stepped wedge trial and will be collected for each SMHI.
Public health impact
The impact of the intervention will be evaluated in
terms of the five dimensions - Reach, Efficacy, Adoption,
Implementation, and Maintenance - of the RE-AIM
framework [43]. All dimensions will be evaluated for
each of the four pillars of SUPREMOCOL, which are 1)
developing and implementing a monitoring system with
decision aid to support professionals in reporting, asses-
sing and monitoring people at risk for suicide, 2)
providing swift access to people registered in the moni-
toring system by specialist crisis teams of SMHIs, 3) po-
sitioning of nurse care managers to collaborate with
psychiatrists in assessment, case management, and guid-
ance to treatment according to the collaborative care
model, and 4) providing telephone monitoring at five
fixed times during 1 year to people registered in the
monitoring system to enhance adherence to treatment.
The RE-AIM dimensions and the variables for the
SUPREMOCOL study are presented in Table 2.
The evaluation of Reach, Efficacy, Adoption, and Im-
plementation will take place during implementation, in
the SMHI areas that are allocated to SUPREMOCOL.
Evaluation of these domains will be specified per SMHI
area and per SWT period (which all last three months).
The evaluation of Maintenance will take place nine
months after the implementation period, will also last
three months and will be evaluated for all SMHI areas
separate, as is presented in Table 3. Each dimension is
represented on a 0% (no impact) to 100% (most optimal
impact) scale. The final Impact score is the function of
these five dimensions, calculated for each SMHI region
and SWT period [43].
Intervention integrity
The integrity of the intervention will be measured dur-
ing implementation and will be derived from the ‘Reach’,
‘Adoption’ and ‘Implementation’ dimensions of the RE-
AIM framework, as can be seen in Table 3. As the integ-
rity of the implementation of the four individual SUPRE-
MOCOL pillars may not equally contribute to the
successful implementation of the intervention in total,
weight distribution between the four pillars will be ap-
plied. The weighing of these four items in the total inter-
vention integrity degree will be determined by the
participating SMHI’s and their chain partners of SUPRE-
MOCOL. For this, the study methods for the weighting
of fidelity items by stakeholders’ ratings by Oxman and
colleagues [46] will be followed. The chain partners will
be asked in a meeting to independently rate the relative
importance of the variables belonging to the four pillars
in successful implementation, by giving a score from 1
to 10 to the four pillars. Mean intervention degree rat-
ings will be calculated, taking into account the weighing
of these items.
Sample size
The sample size calculation is based on completed sui-
cide rates, as this is the primary outcome of this study.
The USA study of which we adapted our systems ap-
proach established a drop in potentially salvageable
deaths from 34% (20/58) to 15% (9/60) (p < .02) follow-
ing implementation, which is a Hazard Ratio of 2.3. We
assume that in trauma patients, compliance of patients
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Table 2 Dimensions and definitions of the RE-AIM framework with variables and data sources
Dimension & definition SUPREMOCOL pillar Variable Data source
Reach
“Proportion of the target
population that participated in
the intervention” [43]
Pillar 1: monitoring system • The number (+ characteristics) of chain
partners that collaborate in the system
versus the number of chain partners that
have been approached for collaboration
• Monitoring system
• Project group logs
• The number (+ characteristics) of SMHI’s
that collaborate in the system versus the
number of SMHI’s that have been
approached for collaboration
• Monitoring system
• Project group logs
Pillar 2: swift access • The number of SMHI’s which are
considering swift access versus the total
number of participating SMHI’s
• Project group logs
• SMHI
Pillar 3: collaborative care • The number of SMHI’s which are
considering to work according to the
collaborative care model versus the total
number of participating SMHI’s
• Project group logs
• SMHI
Pillar 4: 12 months follow up • The number of SMHI’s which are
considering to provide 12 months follow
up versus the total number of
participating SMHI’s
• Monitoring system
• SMHI
Efficacy
“Success rate if implemented as
in guidelines; defined as positive
outcomes minus negative
outcomes” [43]
Pillar 1: monitoring system
Pillar 2: swift access
Pillar 3: collaborative care
Pillar 4: 12 months follow up
• Changes (both positive and negative) in
primary and secondary outcome
measures (suicidal behaviour), as
described in the Methods section
• National and regional health
records
• PHQ-9
• SIDAS
• Monitoring system
• Experiences of patients and professionals
regarding facilitating or hindering factors,
as described in the Methods section
• Online surveys
• Regular meetings
Adoption
“Proportion of settings and
practices that will adopt this
intervention” [43]
Pillar 1: monitoring system • The number (+ characteristics) of chain
partners that made use of the monitoring
system versus the number of chain
partners who have received an account
to this system
• Monitoring system
• The number (+ characteristics) of SMHI
professionals that made use of the
monitoring system versus the number of
SMHI professionals who have received an
account to this system
• Monitoring system
Pillar 2: swift access • The number of SMHI departments that
have the intention to provide swift access
versus the total number of participating
SMHI departments
• SMHI
Pillar 3: collaborative care • The number of SMHI nurses that have
the intention to work according to the
collaborative care model versus the total
number of SMHI nurses in the SMHI
treatment departments
• SMHI
Pillar 4: 12 months follow up • The number of SMHI professionals that
have the intention to provide follow up
contacts versus the total number of SMHI
professionals who received an account to
the monitoring system
• SMHI
Implementation & Maintenance
Implementation
“Extent to which the intervention
is implemented as intended in
the real world” [43]
Pillar 1: monitoring system • The number of successful registrations in
the monitoring system versus the total
number of people attempting suicide
(and were in need of an ambulance ride)
• Monitoring system
• Ambulance records
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Table 2 Dimensions and definitions of the RE-AIM framework with variables and data sources (Continued)
Dimension & definition SUPREMOCOL pillar Variable Data source
Maintenance
“Extent to which a program is
sustained over time” [43]
Implementation and Maintenance
comprise the same variables, however,
Maintenance will be measured
at nine months.
• The number of first contacts that actually
took place versus the number of eligible
persons for a first contact
• Monitoring system
• The number of days, after the day on
which the first contact should have taken
place, the SMHI professional tried to
contact the registered person
• Monitoring system
• The number of days, after the day on
which the first contact should have taken
place, the first contact between the
registered person and the SMHI
professional actually took place
• Monitoring system
Pillar 2: swift access • The number of crisis assessments or
psychiatric consults that were provided
by the SMHI professionals versus the total
number of crisis assessments or
psychiatric consults that were indicated
• Monitoring system
• The number of swift accesses to care that
were arranged by the SMHI professionals
versus the total number of swift
accessses that were indicated
• Monitoring system
• The number of clinical admissions that
were arranged by the SMHI professionals
versus the total number of admissions
that were indicated
• Monitoring system
• The number of people that was referred
to their general practitioner by the SMHI
professionals versus the total number of
people that needed to be referred to
their general practitioner
• Monitoring system
Pillar 3: collaborative care • The number of SMHI professionals that
are involved as case managers versus the
total SMHI professionals that have an
account to the monitoring system
• Project group logs
• The number of contacts with the general
practitioner by the SMHI professionals
versus the total of contacts with the
general practitioner that were indicated
• Monitoring system
• The number of contacts with the
psychiatrist by the SMHI professionals
versus the total of contacts with the
psychiatrist that were indicated
• Monitoring system
Pillar 4: 12 months follow up • The number of eligible persons for a
follow-up monitoring contact versus the
number of follow-up monitoring contacts
that actually took place
• Monitoring system
• The number of days, after the day on
which the follow-up monitoring contact
should have taken place, the SMHI
professional tried to contact the
registered person
• Monitoring system
• The number of days, after the day on
which the follow-up monitoring contact
should have taken place, the follow-up
monitoring contact between the regis
tered person and the SMHI professional
actually took place
• Monitoring system
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with entrance to care, if provided, was 100%, as the
trauma is a one-time occurrence and involuntary. In
people at risk for suicide, this risk may be sustained for
a longer period of time, require multiple entrances into
care and compliance may not always be the case. Hence,
we want to be able to detect a smaller difference, which
is of 20% in the completed suicides, as specified in our
hypothesis. This corresponds to a rate ratio of 1.25.
Based on an alpha of 0.05 (two-sided) and a power of
0.80, for this purpose, the minimal number of events
would be 184 in each year. As completed suicides are the
primary outcome we do not expect any loss to follow up
for that outcome. As in 2017, the number of completed sui-
cides in Noord-Brabant reported by Statistics Netherlands
was 365, and all relevant settings in the region will collabor-
ate, we expect that it will be feasible to find a difference of
20% in completed suicides, if such a difference exists, with
an alpha of 0.05 and a power of 0.80.
Inclusion criteria
People who are registered in the monitoring system will
be invited to participate in a survey evaluating suicidal
ideation by filling out the PHQ-9 and SIDAS question-
naires. Inclusion criteria for participation in this survey
are that participants are 1) 18 years or older and 2)
Dutch-speaking. They will be asked for written informed
consent, as further discussed in paragraph ‘Ethics ap-
proval and consent to participate’.
Statistical methods
To examine whether SUPREMOCOL leads to a reduc-
tion of completed suicides of 20% in the province of
Noord-Brabant, the total number of completed suicides
in the post-measurement will be compared to the total
number of completed suicides in the pre-measurement.
As the total number of residents in this province might
have changed, we will also compare the pre- and post-
incidence rates of suicides. An exact rate ratio test will
be used. To take general trends over time into account,
we will compare the incidence ratio in Noord-Brabant
with the incidence ratios in other provinces in Noord-
Brabant, and with the other provinces combined.
To examine whether SUPREMOCOL leads to a reduc-
tion of completed suicides and suicide attempts in asso-
ciation with the stepwise implementation of the system
intervention in the subregions of the province, the total
number of completed suicides and suicide attempts in
each month will be compared to the two levels of our
stepped wedge trial: region and time. A poison multi-
level model will be used. The occurrence of completed
suicide or admissions due to suicide risk in an SMHI
will also be taken into account in the analysis. The sui-
cide rates will be corrected for seasonal fluctuations
[45]. In a second model, organisational differences be-
tween the regions, such as available number of crisis de-
partments, will be taken into account. In a third model,
the level of treatment integrity per subregion will be
taken into account as well.
To explore whether SUPREMOCOL leads to a reduc-
tion of suicidal ideation in people registered in the mon-
itoring system, the scores on the PHQ-9, SIDAS, and
decision aid -that will be filled out by participants during
the year that they receive the Supremocol additional
care- will be compared by repeated measures. This will
be used as exploratory process evaluation, as there is no
control group for this.
To examine the impact of SUPREMOCOL with
regards to reach, efficacy, adoption, implementation, and
maintenance, an impact score will be calculated for each
SMHI region and time period. This scores will be based
on the function of all five RE-AIM dimensions, which
are represented on a 0% (no impact) to 100% (best pos-
sible impact) scale [43].
Safety and confidentially
Harms
In general, the risk of including suicidal patients in re-
search studies is expected to be low. Huisman and
Table 3 Measurement periods (shaded cells) of the RE-AIM dimensions
Abbreviations: C Cluster, Q quarter of a year, M month, R Reach. E Efficacy, A Adoption, I Implementation, M Maintenance
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Kerkhof (2017) have studied the effects of inclusion of
suicidal participants in scientific research and question-
ing suicidality for scientific research. They found that in-
cluding suicidal people in research trials does not lead to
an increase in completed suicides or suicide attempts
[47]. Furthermore, it has to be stressed that our stepped
wedge trial includes a design that has its effect at the or-
ganisational level, not at the patient level. Hence, people
always receive care as usual. In case a completed suicide
occurs in a person that is registered in the SUPREMO-
COL monitoring system, the suicide will be reported to
the Medical Ethics Committee, the sponsor (GGz Bre-
burg), and the funder (Netherlands Organisation for
Health Research and Development) of this study. A care-
ful and detailed assessment will be made as to whether
there is a link between the suicide and the registration
in the monitoring system. Depending on the outcome,
an advice is given to the parties to end or continue the
trial. In case the Health Care Inspection would prema-
turely terminate the study, the participating organiza-
tions and participants will be fully informed.
Ancillary and post-trial care
In accordance to section 10, subsection 4, of the WMO,
the sponsor of this study, GGz Breburg, will suspend the
study if there is sufficient ground that continuation of
the study will jeopardize the health or safety of patients.
GGz Breburg will notify the Medical Ethics Committee
Brabant without undue delay of a temporary halt includ-
ing the reason for such an action. The study will be sus-
pended pending a further positive decision by the
Medical Ethics Committee Brabant. The investigator will
take care that all participants are kept informed. In
addition, all (serious) adverse events will be reported and
followed until they have abated, or until a stable situ-
ation has been reached. Depending on the event, follow
up may require additional tests or medical procedures as
indicated, and/or referral to the general physician or a
medical specialist.
Confidentiality
The monitoring system will be a web-based system,
encrypted and build on a secured server. A person can
only be registered in this monitoring system if he or she
provides permission for registration. Participants’ data
will be handled confidentially and in accordance with
the Dutch Personal Data Protection Act. A subject iden-
tification code list will be used to link the data to a par-
ticipant. The data of the participating participants are
encrypted and stored under a number that is not trace-
able to their identity. Only the researchers will have ac-
cess to the key of the encryption, which will be stored
separately from the data set. In the publications, the re-
sults cannot be traced to individual participants. The key
to the code will be safeguarded by the researcher, in case
the data will be kept for a longer period of time.
Discussion
In this paper, we aim to outline the development and
design of the SUPREMOCOL study. Implementation
and evaluation of this intervention will be performed by
a stepped wedge trial design and the RE-AIM framework
will be used to evaluate the impact of the intervention.
Several potential strengths and limitations of this study
can be expected.
Potential strengths of the study
This study has three major strengths. First, the stepped
wedge trial design combined with the RE-AIM frame-
work is a strength, as it offers multiple benefits for im-
plementation and evaluation. In our opinion, the SWTD
is the most ethical design, as all areas act as their own
control group, and therefore no areas will be excluded
from the suicide prevention system [41], as we believe
SUPREMOCOL will have considerable added value to
the current care as usual [41, 48]. A stepwise implemen-
tation of the intervention is also highly desirable due to
scientific and practical reasons [41, 48], as it creates the
possibility to control for a time effect by enabling com-
parison between the old and new organization of health
care at the sub-levels of the clusters. Furthermore,
implementing the suicide prevention system on a
provincial-wide scale at once would be rather impracti-
cal and a threat to the feasibility of the project. This
stepwise implementation will make the implementation
more manageable. The combination with the RE-AIM
framework is to our opinion a valuable addition to the
SWTD, as it will provide insight into the impact of the
intervention. This information is useful in the evaluation
of the efficacy of SUPREMOCOL. Moreover, informa-
tion from the perspective of the stakeholders and about
facilitating and hindering factors in implementation
could be used to further improve the prevention system.
A second major strength will be that we choose to
evaluate the efficacy of the intervention with the out-
come parameters completed suicides, suicide attempts,
and suicide ideation. This gives direct information about
the effectiveness of the intervention, as preventing sui-
cide is the ultimate goal of suicide prevention.
Third, it has been argued that effective action towards
reducing suicide would need combined interventions by
different providers in multiple domains [29, 30, 49, 50] –
so-called multilevel interventions [1, 51]. Therefore, we
will not only include (mental) health care institutions
but organizations in all other settings that can partici-
pate by signaling and registering people at risk for sui-
cide in the monitoring system, which is also considered
as a strength of this study [39].
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Potential limitations of the study
We identified two factors that may form potential limita-
tions of our study. A first potential limitation is that
randomization of the starting order of the clusters will
not be feasible as the SMHI’s might be in different
phases in terms of preparation for implementing the
intervention. We identified this potential limitation as
there are, for example, changes and shortages in
personnel within the crisis care departments of the
SMHI’s, which will make the implementation of the
intervention a challenge. However, as discussed in previ-
ous research, although randomization in stepped wedge
trial designs is recommended, the trial might also be
performed without, if it is logistically not feasible [52].
Given the vulnerability of our target group, we will
not assign clusters to the intervention condition if
they are not completely ready, and intervention allo-
cation to the SMHI areas will only be determined
based on six criteria indicating the readiness of the
SMHI for the implementation.
A second potential limitation is that SUPREMOCOL
is not the only suicide prevention initiative that residents
in Noord-Brabant are exposed to. For example, as gate-
keepers training has gained increased attention in the
Netherlands, (mental) health care professionals and
other participating chain partners might have increasing
awareness to and better screening skills for screening
suicide risk. This might be beneficial for the clusters that
start the implementation of SUPREMOCOL on a later
moment. Another example is that some of the partici-
pating organizations operate in the whole province, such
as the railway services. In these organizations, the same
professionals will participate during the whole duration
of our trial, only the geographical areas that are exposed
to the intervention will expand. It is possible that they
will be better trained in delivering the intervention in
the last period of the SWTD, in comparison to period
one, which is also advantageous for clusters that start on
a later moment. Although this might be beneficial for
our outcomes, it might also bias our results.
Contribution of the study
This study has the potential to provide a new effective
suicide prevention intervention for people with a high to
moderate suicide risk as well as to improve the chain of
care. This study will provide valuable information with
regard to the effectiveness of the regional suicide pre-
vention system SUPREMOCOL. Furthermore, the will
create insight into the impact, facilitating and hinder-
ing factors of its implementation. The findings may
give an evidence base for further dissemination of re-
gional suicide prevention systems aiming to reduce
completed suicides, suicide attempts and suicide idea-
tion among citizens.
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